Novartis Has Dropped Some Cancer Drugs From Pipeline, CEO Says
Medicare’s new ability to negotiate some drug prices is a "super high concern," according to CEO Vas Narasimhan.
Stay updated with breaking news from Ceo Interview. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Medicare’s new ability to negotiate some drug prices is a "super high concern," according to CEO Vas Narasimhan.
The Goldman Sachs CEO sat down with Barron's to talk about where the bank is headed, why investors should buy the stock, and how he responds to the critics.
The chief executive is leaning on his thriving truck business in the expensive race for electric vehicles. Investors are hoping that will finally boost the auto maker’s stock price.
CEO Marc Rowan says the alternative asset manager's bet on the retirement services market is paying off.
El-Erian, chief economic advisor at Allianz and chair of Gramercy Funds Management, doesn’t believe the banking sector is in crisis—but he does think the turmoil will have lasting implications.